-
1
-
-
42949119819
-
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
-
Aerts JM, Groenr JE, Kuiper S, et al (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A. 105: 2812-2817.
-
(2008)
Proc Natl Acad Sci U S A.
, vol.105
, pp. 2812-2817
-
-
Aerts, J.M.1
Groenr, J.E.2
Kuiper, S.3
-
2
-
-
0034943172
-
Enhanced endothelium-dependent vasodilatation in Fabry disease
-
Altarescu G, Moore DF, Pursley R, et al (2001) Enhanced endothelium-dependent vasodilatation in Fabry disease. Stroke 32: 1559-1562.
-
(2001)
Stroke
, vol.32
, pp. 1559-1562
-
-
Altarescu, G.1
Moore, D.F.2
Pursley, R.3
-
3
-
-
33646691525
-
Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease
-
doi: 10.1080/08035320600618924
-
Barbey F, Brakch N, Linhart A, et al (2006a) Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 95: 63-68. doi: 10.1080/08035320600618924.
-
(2006)
Acta Paediatr Suppl
, vol.95
, pp. 63-68
-
-
Barbey, F.1
Brakch, N.2
Linhart, A.3
-
4
-
-
33646680506
-
Cardiac and vascular hypertrophy in Fabry disease. Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition
-
doi: 10.1161/01.ATV.0000209649.60409.38
-
Barbey F, Brakch N, Linhart A, et al (2006b) Cardiac and vascular hypertrophy in Fabry disease. Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26: 839-844. doi: 10.1161/01.ATV.0000209649.60409.38.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 839-844
-
-
Barbey, F.1
Brakch, N.2
Linhart, A.3
-
5
-
-
0034852918
-
Non-invasive evaluation of arterial involvement in patients affected with Fabry disease
-
doi: 10.1136/jmg.38.9.629
-
Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2001) Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 38: 629-631. doi: 10.1136/ jmg.38.9.629.
-
(2001)
J Med Genet
, vol.38
, pp. 629-631
-
-
Boutouyrie, P.1
Laurent, S.2
Laloux, B.3
Lidove, O.4
Grunfeld, J.P.5
Germain, D.P.6
-
6
-
-
0018924075
-
Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease
-
doi: 10.1016/0021-9150(80)90081-7
-
Clarke JT, Stolz JM, Garner JB (1980) Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease. Atherosclerosis 35: 155-163. doi: 10.1016/ 0021-9150(80)90081-7.
-
(1980)
Atherosclerosis
, vol.35
, pp. 155-163
-
-
Clarke, J.T.1
Stolz, J.M.2
Garner, J.B.3
-
7
-
-
23844484627
-
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population
-
doi: 10.1007/s00109-005-0656-2
-
Dobrovolny R, Dvorakova L, Ledvinova J, et al (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83: 647-654. doi: 10.1007/ s00109-005-0656-2.
-
(2005)
J Mol Med
, vol.83
, pp. 647-654
-
-
Dobrovolny, R.1
Dvorakova, L.2
Ledvinova, J.3
-
8
-
-
1642455933
-
Sequelae of storage in fabry disease - Pathology and comparison with other lysosomal storage diseases
-
Elleder M (2003) Sequelae of storage in fabry disease - pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 443: 46-53.
-
(2003)
Acta Paediatr Suppl
, vol.443
, pp. 46-53
-
-
Elleder, M.1
-
9
-
-
0025049304
-
Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy
-
doi: 10.1007/BF01606034
-
Elleder M, Bradová V, Smíd F, et al (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417: 449-455. doi: 10.1007/ BF01606034.
-
(1990)
Virchows Arch A Pathol Anat Histopathol
, vol.417
, pp. 449-455
-
-
Elleder, M.1
Bradová, V.2
Smíd, F.3
-
10
-
-
33644524081
-
Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase
-
doi: 10.1136/hrt.2004.054015
-
Elliott PM, Kindler H, Shah JS, et al (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase. Heart 92: 357-360. doi: 10.1136/ hrt.2004.054015.
-
(2006)
Heart
, vol.92
, pp. 357-360
-
-
Elliott, P.M.1
Kindler, H.2
Shah, J.S.3
-
11
-
-
0026623293
-
Fabry disease: An unusual cause of severe coronary disease in a young man
-
Ficher EA, Desnick RJ, Gordon RE, Eng CM, Griepp R, Goldman ME (1992) Fabry disease: An unusual cause of severe coronary disease in a young man. Ann Intern Med 117: 221-223.
-
(1992)
Ann Intern Med
, vol.117
, pp. 221-223
-
-
Ficher, E.A.1
Desnick, R.J.2
Gordon, R.E.3
Eng, C.M.4
Griepp, R.5
Goldman, M.E.6
-
12
-
-
0036626870
-
Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease
-
doi: 10.1034/j.1399-0004.2002.610605.x
-
Heltianu C, Costache G, Azibi K, Poenaru L, Simionescu M (2002) Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease. Clin Genet 61: 423-429. doi: 10.1034/j.1399-0004.2002.610605.x.
-
(2002)
Clin Genet
, vol.61
, pp. 423-429
-
-
Heltianu, C.1
Costache, G.2
Azibi, K.3
Poenaru, L.4
Simionescu, M.5
-
13
-
-
0033222974
-
[Postmortem diagnosis of fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the
-
Ho̊lková H, Ledvinová J, Poupětová H, Bultas J, Zeman J, Elleder M (2000) [Postmortem diagnosis of fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the family]. Cas Lek Cesk 138: 660-664.
-
(2000)
Family] Cas Lek Cesk
, vol.138
, pp. 660-664
-
-
Ho̊lková, H.1
Ledvinová, J.2
Poupětová, H.3
Bultas, J.4
Zeman, J.5
Elleder, M.6
-
14
-
-
19944377541
-
Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease
-
doi: 10.1007/s10545-005-0563-2
-
Kalliokoski RJ, Kalliokoski KK, Sundell J, et al (2005) Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease. J Inherit Metab Dis 28: 563-573. doi: 10.1007/s10545-005-0563-2.
-
(2005)
J Inherit Metab Dis
, vol.28
, pp. 563-573
-
-
Kalliokoski, R.J.1
Kalliokoski, K.K.2
Sundell, J.3
-
15
-
-
33645694070
-
The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease
-
doi: 10.1007/s10545-006-0221-3
-
Kalliokoski RJ, Kantola I, Kalliokoski KK, et al (2006) The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease. J Inherit Metab Dis 29: 112-118. doi: 10.1007/ s10545-006-0221-3.
-
(2006)
J Inherit Metab Dis
, vol.29
, pp. 112-118
-
-
Kalliokoski, R.J.1
Kantola, I.2
Kalliokoski, K.K.3
-
16
-
-
0034001563
-
Fabry disease: Ultrastructural lectin histochemical analyses of lysosomal deposits
-
doi: 10.1007/PL00008196
-
Kanda A, Nakao S, Tsuyama S, Murata F, Kanzaki T (2000) Fabry disease: ultrastructural lectin histochemical analyses of lysosomal deposits. Virchows Arch 436: 36-42. doi: 10.1007/PL00008196.
-
(2000)
Virchows Arch
, vol.436
, pp. 36-42
-
-
Kanda, A.1
Nakao, S.2
Tsuyama, S.3
Murata, F.4
Kanzaki, T.5
-
17
-
-
33746318436
-
Prevalence of uncontrolled hypertension in patients with fabry disease
-
doi: 10.1016/j.amjhyper.2006.01.011
-
Kleinert J, Dehout F, Schwarting A, et al (2006) Prevalence of uncontrolled hypertension in patients with fabry disease. Am J Hypertens 19: 782-787. doi: 10.1016/j.amjhyper.2006.01.011.
-
(2006)
Am J Hypertens
, vol.19
, pp. 782-787
-
-
Kleinert, J.1
Dehout, F.2
Schwarting, A.3
-
18
-
-
57649201260
-
TREASURE study: IntRavascular ultRasound Evaluation of Atherosclerosis regreSsion Using atoRvastatin thErapy
-
[Abstract]
-
Kovarnik T, Reznícek V, Novackova K, Horak J, Simek S, Aschermann M (2003) TREASURE study: IntRavascular ultRasound Evaluation of Atherosclerosis regreSsion Using atoRvastatin thErapy. Am J Cardiol 92 (Suppl.197L). [Abstract].
-
(2003)
Am J Cardiol
, vol.92
, Issue.SUPPL. 197L
-
-
Kovarnik, T.1
Reznícek, V.2
Novackova, K.3
Horak, J.4
Simek, S.5
Aschermann, M.6
-
19
-
-
0035149822
-
Cardiac manifestations in Fabry disease
-
doi: 10.1023/A:1012428009627
-
Linhart A, Lubanda J-C, Palecek T, et al (2001) Cardiac manifestations in Fabry disease. J Inherit Metab Dis 24 (Suppl 2): 75-83. doi: 10.1023/ A:1012428009627.
-
(2001)
J Inherit Metab Dis
, vol.24
, Issue.SUPPL. 2
, pp. 75-83
-
-
Linhart, A.1
Lubanda, J.-C.2
Palecek, T.3
-
20
-
-
34548316207
-
Cardiac manifestations of Anderson-Fabry disease: Results from the international Fabry outcome survey
-
doi: 10.1093/eurheartj/ehm153
-
Linhart A, Kampmann C, Zamorano JL, et al (2007) Cardiac manifestations of Anderson-Fabry disease: Results from the international Fabry outcome survey. Eur Heart J 28: 1228-1235. doi: 10.1093/eurheartj/ehm153.
-
(2007)
Eur Heart J
, vol.28
, pp. 1228-1235
-
-
Linhart, A.1
Kampmann, C.2
Zamorano, J.L.3
-
21
-
-
0034766525
-
Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 98 hemizygous males
-
doi: 10.1136/jmg.38.11.750
-
MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38: 750-760. doi: 10.1136/jmg.38.11.750.
-
(2001)
J Med Genet
, vol.38
, pp. 750-760
-
-
MacDermot, K.D.1
Holmes, A.2
Miners, A.H.3
-
22
-
-
0035312809
-
American College of Cardiology Clinical Expert Consensus Document on Standards for Aquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
-
doi: 10.1016/S0735-1097(01)01175-5
-
Mintz GS, Nissen S (2001) American College of Cardiology Clinical Expert Consensus Document on Standards for Aquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37: 1478-1492. doi: 10.1016/ S0735-1097(01)01175-5.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1478-1492
-
-
Mintz, G.S.1
Nissen, S.2
-
23
-
-
0035949721
-
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: Reversal by enzyme replacement therapy
-
doi: 10.1161/hc3801.096352
-
Moore DF, Scott LT, Gladwin MT, et al (2001) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104: 1506-1512. doi: 10.1161/hc3801.096352.
-
(2001)
Circulation
, vol.104
, pp. 1506-1512
-
-
Moore, D.F.1
Scott, L.T.2
Gladwin, M.T.3
-
24
-
-
18244397953
-
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement
-
Moore DF, Altarescu G, Ling GS, et al (2002) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33: 525-531.
-
(2002)
Stroke
, vol.33
, pp. 525-531
-
-
Moore, D.F.1
Altarescu, G.2
Ling, G.S.3
-
25
-
-
4744344117
-
Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality - An arterial spin tagging study
-
doi: 10.1002/jmri.20162
-
Moore DF, Ye F, Brennan ML, et al (2004) Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality - an arterial spin tagging study. J Magn Reson Imaging 20: 674-683. doi: 10.1002/jmri.20162.
-
(2004)
J Magn Reson Imaging
, vol.20
, pp. 674-683
-
-
Moore, D.F.1
Ye, F.2
Brennan, M.L.3
-
26
-
-
3042948394
-
Vasospastic angina in a patient with Fabry's disease who showed normal coronary angiographic findings
-
doi: 10.1253/jcj.60.315
-
Ogawa T, Kawai M, Matsui T, et al (1996) Vasospastic angina in a patient with Fabry's disease who showed normal coronary angiographic findings. Jpn Circ J 60: 315-318. doi: 10.1253/jcj.60.315.
-
(1996)
Jpn Circ J
, vol.60
, pp. 315-318
-
-
Ogawa, T.1
Kawai, M.2
Matsui, T.3
-
27
-
-
0028354071
-
Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables
-
doi: 10.1016/0002-9149(94)90876-1
-
Rasheed Q, Nair R, Sheehan H, McB Hodgson J (1994) Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables. Am J Cardiol 73: 753-758. doi: 10.1016/0002-9149(94)90876-1.
-
(1994)
Am J Cardiol
, vol.73
, pp. 753-758
-
-
Rasheed, Q.1
Nair, R.2
Sheehan, H.3
Hodgson, J.McB.4
-
28
-
-
24944513802
-
Prevalence and clinical significance of cardiac arrhythmias in Anderson-Fabry disease
-
doi: 10.1016/j.amjcard.2005.05.033
-
Shah JS, Hughes DA, Sachdev B, et al (2005) Prevalence and clinical significance of cardiac arrhythmias in Anderson-Fabry disease. Am J Cardiol 96: 842-846. doi: 10.1016/j.amjcard.2005.05.033.
-
(2005)
Am J Cardiol
, vol.96
, pp. 842-846
-
-
Shah, J.S.1
Hughes, D.A.2
Sachdev, B.3
-
29
-
-
33644830752
-
Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement
-
doi: 10.1007/s00428-005-0089-x
-
Schiffmann R, Rapkiewitz A, Abu-Asab M, et al (2006) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 448: 337-343. doi: 10.1007/ s00428-005-0089-x.
-
(2006)
Virchows Arch
, vol.448
, pp. 337-343
-
-
Schiffmann, R.1
Rapkiewitz, A.2
Abu-Asab, M.3
-
30
-
-
0034244345
-
Atypical Fabry's disease presenting with cholesterol crystal embolization
-
Shirai T, Ohtake T, Kimura M, et al (2000) Atypical Fabry's disease presenting with cholesterol crystal embolization. Intern Med 39: 646-649.
-
(2000)
Intern Med
, vol.39
, pp. 646-649
-
-
Shirai, T.1
Ohtake, T.2
Kimura, M.3
-
31
-
-
0026099642
-
An atypical variant of Fabry's disease with manifestation confined to the myocardium
-
von Scheidt W, Eng CM, Fitzmaurice TF, et al (1991) An atypical variant of Fabry's disease with manifestation confined to the myocardium. N Engl J Med 324: 395-399.
-
(1991)
N Engl J Med
, vol.324
, pp. 395-399
-
-
von Scheidt, W.1
Eng, C.M.2
Fitzmaurice, T.F.3
|